Globe Life Inc. $GL Shares Sold by Stephens Inc. AR

Stephens Inc. AR trimmed its holdings in Globe Life Inc. (NYSE:GL) by 82.9% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 4,806 shares of the company’s stock after selling 23,255 shares during the period. Stephens Inc. AR’s holdings in Globe Life were worth $597,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in GL. Global Assets Advisory LLC acquired a new stake in Globe Life in the 2nd quarter worth about $25,000. AdvisorNet Financial Inc boosted its stake in Globe Life by 60.0% in the 2nd quarter. AdvisorNet Financial Inc now owns 224 shares of the company’s stock worth $28,000 after buying an additional 84 shares during the last quarter. TD Private Client Wealth LLC acquired a new stake in Globe Life in the 2nd quarter worth about $39,000. SouthState Corp acquired a new stake in Globe Life in the 1st quarter worth about $43,000. Finally, Ransom Advisory Ltd acquired a new stake in Globe Life in the 1st quarter worth about $50,000. 81.61% of the stock is owned by institutional investors and hedge funds.

Globe Life Stock Performance

Globe Life stock opened at $133.67 on Friday. The stock’s 50 day moving average price is $139.54 and its 200 day moving average price is $129.57. The firm has a market capitalization of $10.83 billion, a PE ratio of 9.69 and a beta of 0.55. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.06 and a current ratio of 0.06. Globe Life Inc. has a one year low of $100.27 and a one year high of $147.83.

Globe Life (NYSE:GL) last released its quarterly earnings results on Wednesday, October 22nd. The company reported $4.81 EPS for the quarter, topping the consensus estimate of $4.54 by $0.27. The firm had revenue of $1.51 billion for the quarter, compared to analyst estimates of $1.52 billion. Globe Life had a return on equity of 22.12% and a net margin of 19.36%.During the same period in the previous year, the company posted $3.44 EPS. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS. FY 2025 guidance at 14.400-14.600 EPS. As a group, sell-side analysts expect that Globe Life Inc. will post 13.87 EPS for the current fiscal year.

Globe Life Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, October 3rd will be given a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, October 3rd. This represents a $1.08 annualized dividend and a yield of 0.8%. Globe Life’s payout ratio is 7.83%.

Insider Buying and Selling

In other Globe Life news, EVP Michael Clay Majors sold 10,000 shares of Globe Life stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $137.41, for a total transaction of $1,374,100.00. Following the sale, the executive vice president directly owned 47,066 shares in the company, valued at $6,467,339.06. The trade was a 17.52% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Frank M. Svoboda sold 12,500 shares of Globe Life stock in a transaction that occurred on Thursday, July 31st. The stock was sold at an average price of $141.38, for a total value of $1,767,250.00. Following the sale, the chief executive officer owned 32,747 shares in the company, valued at $4,629,770.86. This represents a 27.63% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 51,452 shares of company stock valued at $7,222,713. Corporate insiders own 1.51% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on GL shares. Truist Financial lifted their price objective on Globe Life from $150.00 to $158.00 and gave the company a “buy” rating in a research note on Friday. Cfra Research raised Globe Life to a “moderate buy” rating in a research note on Friday, July 25th. Keefe, Bruyette & Woods lifted their price objective on Globe Life from $145.00 to $155.00 and gave the company an “outperform” rating in a research note on Monday, July 28th. Wells Fargo & Company reduced their price objective on Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a research note on Friday. Finally, JPMorgan Chase & Co. lifted their price objective on Globe Life from $145.00 to $160.00 and gave the company an “overweight” rating in a research note on Tuesday, July 8th. Eight analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Globe Life has an average rating of “Moderate Buy” and an average price target of $152.78.

Globe Life Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.